CLINICAL FEATURES AND COURSE OF PULMONARY TUBERCULOSIS IN PATIENTS WITH DIABETES MELLITUS
- Authors
-
-
Kurbanov Alisher Khushbakaevich
Assistant Professor at the Department of Infectious Diseases, Pediatric Infectious Diseases, Phthisiology and Pulmonology Tashkent State Medical University
Author
-
- Keywords:
- Pulmonary tuberculosis, diabetes mellitus, comorbidity, hyperglycemia, immune dysfunction, treatment outcomes.
- Abstract
-
Tuberculosis (TB) remains one of the leading infectious causes of morbidity and mortality worldwide. Concurrently, the global prevalence of diabetes mellitus (DM) continues to rise, creating a significant challenge for healthcare systems. Diabetes mellitus is recognized as an important risk factor for the development, progression, and unfavorable outcomes of pulmonary tuberculosis. The coexistence of these two diseases alters the clinical presentation, radiological manifestations, immune response, and treatment outcomes. Hyperglycemia impairs both innate and adaptive immunity, increasing susceptibility to Mycobacterium tuberculosis infection and reactivation of latent tuberculosis. Patients with diabetes frequently demonstrate more extensive pulmonary lesions, delayed sputum conversion, increased bacterial load, and higher rates of treatment failure and relapse. This review summarizes current evidence regarding the peculiarities of pulmonary tuberculosis in patients with diabetes mellitus, including epidemiological trends, pathogenetic mechanisms, clinical manifestations, diagnostic challenges, and therapeutic considerations.
- References
-
1.Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis. Lancet Infect Dis. 2008.
2.Baker MA, Harries AD, Jeon CY et al. The impact of diabetes on tuberculosis treatment outcomes. BMC Medicine. 2011.
3.Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus. Lancet Infectious Diseases. 2009.
4.Restrepo BI. Diabetes and tuberculosis. Microbiology Spectrum. 2016.
5.Magee MJ, Bloss E, Shin SS et al. Clinical characteristics of patients with tuberculosis and diabetes. Int J Tuberc Lung Dis. 2013.
6.Alisjahbana B et al. The effect of type 2 diabetes mellitus on pulmonary tuberculosis treatment outcomes. Clin Infect Dis. 2007.
7.Ruslami R et al. Implications of diabetes mellitus in tuberculosis. Clinical Infectious Diseases. 2010.
8.Lee PH et al. Radiographic presentation of pulmonary tuberculosis in diabetic patients. Chest. 2017.
9.Martinez N, Kornfeld H. Diabetes and immunity to tuberculosis. Eur J Immunol. 2014.
10.Kumar NP et al. Impact of diabetes mellitus on immunity in tuberculosis. Front Immunol. 2019.
- Downloads
- Published
- 2026-06-04
- Issue
- Vol. 2 No. 5 (2026)
- Section
- Articles
- License
-
This work is licensed under a Creative Commons Attribution 4.0 International License.
